Presidio Medical Stock
Presidio Medical is developing a next-generation neuromodulation platform that delivers bioelectronic therapies for chronic pain. Its technology is designed to mimic natural neural signals for more effective and paresthesia-free pain relief, offering an alternative to traditional spinal cord stimulation.
For more Presidio Medical stock information, or to buy or sell private shares, sign up for a MicroVentures account.
Management Team
| Michael Onuscheck Chief Executive Officer |
| Mark Murray Chief Financial Officer |
| Andrew Sullivan Chief Medical Officer |
